|
|
Volumn , Issue , 2015, Pages e352-e359
|
|
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: a broader range of options, improved outcomes, and more therapeutic dilemmas
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PROTEIN TYROSINE KINASE;
ADULT;
ALLOTRANSPLANTATION;
ANTAGONISTS AND INHIBITORS;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MIDDLE AGED;
MOLECULARLY TARGETED THERAPY;
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;
PROCEDURES;
REMISSION;
SECONDARY PREVENTION;
TREATMENT OUTCOME;
ADULT;
ANTINEOPLASTIC AGENTS;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
MIDDLE AGED;
MOLECULAR TARGETED THERAPY;
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;
PROTEIN-TYROSINE KINASES;
REMISSION INDUCTION;
SECONDARY PREVENTION;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
|
EID: 85003977065
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.14694/EdBook_AM.2015.35.e352 Document Type: Review |
|
Times cited : (31)
|
|
References (0)
|